Physician profile
Mosayeb Karimi
NPI 1235895095
$480.53
in general payments reported to CMS, 2019-2025
8 companies · $11.10 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $422 · 2024: $47.90 · 2025: $11.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $129.17 | 2023 | Auryon Laser System 100-120 Vac |
| Bsn Medical INC | $108.90 | 2023-2024 | |
| Epsfl, LLC | $95.46 | 2023 | |
| Smith+Nephew, INC. | $49.43 | 2023 | Collagenase Santyl, Iodosorb Ointment 40g USA, Regranex |
| Kerecis Limited | $35.98 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Reprise Biomedical, INC. | $34.13 | 2024 | Miro3d |
| Polymedics Innovations INC. | $16.36 | 2023 | |
| Molnlycke Health Care US, LLC | $11.10 | 2025 | Mextra Superabsorbant, Mepitel, Exufiber Ag+ |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mosayeb Karimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.